Product CAS No

231277-92-2

Product Description

Lapatinib is classified as a signal transduction inhibitor – tyrosine kinase inhibitor, an inhibitor of EGFR and HER2.

Therapeutic Action

Lapatinib used in the form of lapatinib ditosylate, It is an orally active drug for breast cancer and other solid tumors. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress.